ponents of extracorporeal systems such as in cardiopulmonary bypass, extracorporeal membrane oxygenation, and dialysis circuits. [1] Despite their ubiquitous usage, they are prone to eliciting untoward patient outcomes owing to shear-induced blood cell damage and device-induced thrombosis. [2] These manifest in potentially fatal complications such as device failure, ischemic/embolic strokes, hemolytic anemia, and even acute kidney injury. [3] Shear stresses in medical devices can reach as high as 900 Pa in roller pumps used in cardiopulmonary bypass [4] and up to 4000 Pa in ventricular assist devices. [5] Such high stresses are inevitable in order for devices to reach necessary pumping function, but causes a myriad of blood dysfunctions. Previous studies have shown that shear stresses above 50 Pa are sufficient to induce platelet activation. [6] This was mediated by shear-induced stretching of von Willebrand factor (vWF) that exposes and activates binding sites for platelet receptor gylocoprotein 1bα (GP1bα), and shearinduced activation of platelet integrin α IIb β 3 . Subsequently, platelet aggregation occurs to lead to thrombosis. [7] High blood shear stresses can also activate neutrophils, trigger NETosis Blood-contacting medical devices are often associated with shear-induced and contact activation thrombosis. Superhydrophobic materials have shown promise to reduce flow drag forces, but not contact activation. Here, a strategy of selectively grafting a potent anti-thrombin compound on the tips of the surface microstructures of a superhydrophobic polytetrafluoroethylene foam, is presented, to concurrently achieve drag reduction and antithrombosis. This work shows that two grafting approaches -Argon plasma or piranha solution treatment -followed by covalent cross-linking can successfully graft the drug to the outer tips of the foam and provide antithrombotic functionality. By avoiding grafting to the inner regions of the foam, the surface's drag reduction properties can be retained. The functional durability of the grafted surfaces is evaluated by strong water jetting, which demonstrates that the plasma approach can withstand substantial fluid shearing but not the piranha approach, although the plasma approach involves stronger compromise to the drag reduction capabilities. As the proposed selective grafting strategy is applied to a bulk foam, it can be complemented with a previously proposed strategy of supplying air pressure to the foam pores to bolster resistance to fluid impalement and plastron dissolution, allowing the material to be used in medical devices with high fluid pressures.